Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems
(Thomson Reuters ONE) -
Tecan Group AG / Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
Männedorf, Switzerland, September 2, 2010 - The Tecan Group (SIX Swiss Exchange:
TECN) today announced that the sale of REMP AG, a wholly owned subsidiary of
Tecan, as well as other related assets, to NEXUS Biosystems has been completed
as planned. From September 1, 2010, the Sample Management business segment will
no longer be consolidated within the Tecan Group. It will be presented in the
2010 financial statements as a discontinued operation.
Tecan announced on July 15, 2010 that it would sell all the activities of the
Sample Management business segment to NEXUS as part of its strategic portfolio
alignment. Tecan will now focus its resources on growth projects in its core
business and actively expand both its end-customer business and its OEM
activities.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics, and clinical diagnostics. The
company specializes in the development, production and distribution of
instruments and automated workflow solutions for laboratories in the life
sciences sector. Its clients include pharmaceutical and biotechnology companies,
university research departments, forensic and diagnostic laboratories. As an
original equipment manufacturer, Tecan is also a leader in developing and
manufacturing OEM instruments and components that are then distributed by
partner companies. Founded in Switzerland in 1980, the company has
manufacturing, research and development sites in both Europe and North America
and maintains a sales and service network in 52 countries. In 2009, Tecan
generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million).
Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK:
TECN/Reuters: TECZn.S/ ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
[HUG#1442092]
--- End of Message ---
Tecan Group AG
Seestrasse 103 Männedorf Switzerland
ISIN: CH0012100191;
Press Release (PDF):
http://hugin.info/100384/R/1442092/386371.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Tecan Group AG via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 02.09.2010 - 07:25 Uhr
Sprache: Deutsch
News-ID 40982
Anzahl Zeichen: 0
contact information:
Town:
Männedorf
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 192 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems"
steht unter der journalistisch-redaktionellen Verantwortung von
Tecan Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
